Ad is loading...
MENU

LPTX Leap Therapeutics Forecast, Technical & Fundamental Analysis

a company, which engages in clinical stage immuno-oncology

Industry Biotechnology
LPTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
LPTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

LPTX is expected to report earnings to fall 72.50% to -8 cents per share on August 11

Leap Therapeutics LPTX Stock Earnings Reports
Q2'23
Est.
$-0.09
Q1'23
Missed
by $0.23
Q4'22
Est.
$-0.11
Q3'22
Missed
by $0.01
Q2'22
Missed
by $0.05
The last earnings report on May 15 showed earnings per share of -31 cents, missing the estimate of -8 cents. With 322.36K shares outstanding, the current market capitalization sits at 104.84M.
A.I. Advisor
published General Information

General Information

a company, which engages in clinical stage immuno-oncology

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
47 Thorndike Street
Phone
+1 617 714-0360
Employees
54
Web
https://www.leaptx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CEIN0.02N/A
+3.17%
Camber Energy, Inc.
AXAHY35.740.43
+1.22%
AXA
TLPFY47.700.57
+1.22%
Teleperformance
EJPRY9.330.07
+0.76%
East Japan Railway Co.
FCUUF0.54-0.01
-1.52%
Fission Uranium Corp.

LPTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, LPTX has been loosely correlated with AXON. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if LPTX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LPTX
1D Price
Change %
LPTX100%
-5.19%
AXON - LPTX
40%
Loosely correlated
-0.86%
AMRN - LPTX
35%
Loosely correlated
-3.85%
FBIO - LPTX
32%
Poorly correlated
-8.92%
ALLR - LPTX
30%
Poorly correlated
-6.38%
ARRY - LPTX
30%
Poorly correlated
-10.22%
More